OT
Insider
Ourania Tatsis
EVP, Chief Reg. & Quality Off.Ourania Tatsis (EVP, Chief Reg. & Quality Off.) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $2.1M of VRTX (4,500 sh × $474.99, as filed), executed Jan 7.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.5M
shares × price, as filed
Last traded
Jul 2
Filed Jul 7
Median ADV $756.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $10.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
VRTX
Vertex Pharmaceuticals Incorporated
VRTX · 0 buys · 13 sells
13 filings
Recent filings
VRTXSALE
Vertex Pharmaceuticals Incorporated
View filing →
$2.0M4,058 sh × $485.49
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $252K
530 sh × $475.34
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $170K
354 sh × $480.95
Exec Feb 25 2025
Filed Feb 26 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $111K
244 sh × $455.06
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $143K
310 sh × $459.83
Exec Feb 11 2025
Filed Feb 12 2025 · 5:30 PM ET